UTI Medium to Long Term Fund

A Medium to Long Term Fund scheme from UTI Mutual Fund. Figures below are for the Direct · Growth plan (ISIN INF789F01SQ6).

NAV ₹83.3098 on 16 November 2026.

Expense ratio

Total expense ratio 1.32% a year for the Direct · Growth plan, as AMFI published it on 29 October 2026: base expense ratio 1.12%, brokerage 0.00%, transaction costs 0.00%, statutory levies including GST 0.20%.

Returns and risk

PeriodReturn a yearVolatilityWorst fallSharpeSortino
1 year2.9%2.1%-1.4%-1.97-1.89
3 years6.2%2.0%-1.6%-0.40-0.40
5 years6.9%4.2%-2.2%-0.03-0.06
10 years5.1%4.9%-13.1%-0.39-0.42

Not ranked in its category: no rank is available.

Largest holdings

Top 10 (September 2026 disclosure). Company shares make up 0.0% of the portfolio.

  1. 6.90% GSEC MAT - 15/04/2065 (debt) — 8.87%
  2. NCD SUMMIT DIGITEL INFRASTRUCTURE LTD (debt) — 8.18%
  3. NCD BAJAJ HOUSING FINANCE LTD (debt) — 8.10%
  4. 7.08% A P SGL MAT - 26/03/2037 (debt) — 7.75%
  5. 07.80% XIRR PTC- SIDDHIVINAYAK SECURITISATION TRUST-28/09/2030 (debt) — 6.30%
  6. SPN/DDB JTPM METAL TRADERS LIMITED (debt) — 5.69%
  7. NCD MUTHOOT FINANCE LTD (debt) — 5.60%
  8. NCD PIRAMAL FINANCE LIMITED (debt) — 4.96%
  9. NCD ADITYA BIRLA RENEWABLES LTD (debt) — 4.94%
  10. Torrent Pharmaceuticals Limited (debt) — 4.89%

Plans

Other funds in Medium to Long Term Fund

All 14 funds in Medium to Long Term Fund · Compare this fund with another

Past returns are history, not a forecast. XIRRO describes funds and portfolios; it is information, not investment advice.